Defactinib

About

Therapy type: Targeted therapy

Therapy strategy: FAK inhibition

Mappings

NCI Thesaurus: Defactinib (coding:ncit:C79809)

RxNorm: defactinib (coding:rxcui:2714502, coding:omop:37353190)

Therapeutic response

Precision oncology relationships for therapeutic response involving this therapy.

Organizations Biomarkers Cancer types Therapies
FDA (1) KRAS p.G12C Low-Grade Serous Ovarian Cancer Avutometinib, Defactinib
FDA (1) KRAS p.G12V Low-Grade Serous Ovarian Cancer Avutometinib, Defactinib